Teshamae Monteith
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $74,213 of the $91,907 with a category attached, or 80.7%. 13 manufacturers reported payments, led by Pfizer at 28.7% of the total. Reporting peaked in 2024 at $26,282 and has fallen 52.4% since, to $12,521 in 2025. Among neurology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $858.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$26K
- Merz Pharmaceuticals, LLC$21K
- Lundbeck LLC$14K
- Novartis Pharma AG$9K
- Teva Pharmaceuticals USA, Inc.$7K
- AbbVie$6K
- plus $8K from 7 others
Across 64 payments — averaging $4304.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$125K
- Eli Lilly$61K
- Ipsen Innovation$24K
- Novartis$22K
- Amgen$19K
- Teva Pharmaceuticals USA, Inc.$17K
- plus $8K from 1 others
What the payments were for
- Consulting fees$74,21381%
- Speaking & faculty fees$10,00011%
- Travel & lodging$4,5935%
- Food & beverage$3,0523%
- Education$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 17 | $26,393 |
| Merz Pharmaceuticals, LLC | 6 | $21,089 |
| Lundbeck LLC | 18 | $13,962 |
| Novartis Pharma AG | 4 | $8,798 |
| Teva Pharmaceuticals USA, Inc. | 3 | $7,493 |
| AbbVie(2 entities) | 42 | $6,192 |
| Amneal Pharmaceuticals LLC | 1 | $3,000 |
| Amgen | 6 | $2,422 |
| Biogen | 1 | $1,250 |
| Ipsen Innovation | 4 | $1,105 |
| Lilly USA, LLC | 2 | $97 |
| Impel Pharmaceuticals Inc. | 2 | $71 |
| UCB, Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$91,907 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 91 | $73,983 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 25 | $22,249 |
| Aimovig AutoinjectorErenumab-Aooe | 21 | $14,894 |
| Ajovy SyringeFremanezumab-Vfrm | 12 | $11,298 |
| Eletriptan HbrEletriptan Hydrobromide | 14 | $991 |
| RizatriptanRizatriptan Benzoate | 24 | $406 |
| Topiramate | 20 | $343 |
| Naratriptan Hcl | 17 | $262 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $189 |
| Sumatriptan Succinate | 24 | $176 |
| Ketorolac Tromethamine | 15 | $96 |
| Naproxen | 27 | $91 |
| Gabapentin | 12 | $81 |
| Metoclopramide Hcl | 20 | $26 |
Paid to pharmacies, not to this prescriber.
Other neurology in Miami
- Diego Torres-RussottoMiami$652K
- Bruno GalloMiami$313K
- Brad HerskowitzMiami$273K
- Flavia NelsonMiami$264K
- Corneliu LucaMiami$257K
- Kottil RammohanMiami$176K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.